Stay updated on Venetoclax Combination for Higher-Risk MDS Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combination for Higher-Risk MDS Clinical Trial page.

Latest updates to the Venetoclax Combination for Higher-Risk MDS Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page history, a minor version change that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new history entry 'Revision: v3.3.3' was added, and the 'HHS Vulnerability Disclosure' link along with the earlier 'Revision: v3.3.2' entry were removed.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page footer now displays 'Revision: v3.3.2' in place of 'Revision: v3.2.0'.SummaryDifference0.0%

- Check59 days agoChange DetectedRemoved the standard government funding/operating-status notice from the page.SummaryDifference0.3%

- Check74 days agoChange DetectedThe newer screenshot shows additional history entries in the Record History page, but there is no visible change to core trial data such as status, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check103 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference8%

Stay in the know with updates to Venetoclax Combination for Higher-Risk MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combination for Higher-Risk MDS Clinical Trial page.